These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
147 related items for PubMed ID: 16266872
1. [Advantage of immunochemical fecal occult blood test in screening for colorectal cancer]. Launoy G, Berchi C. Bull Cancer; 2005 Oct; 92(10):885-90. PubMed ID: 16266872 [Abstract] [Full Text] [Related]
2. Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Launoy GD, Bertrand HJ, Berchi C, Talbourdet VY, Guizard AV, Bouvier VM, Caces ER. Int J Cancer; 2005 Jun 20; 115(3):493-6. PubMed ID: 15700317 [Abstract] [Full Text] [Related]
6. [Improvement in screening for colorectal cancer associated with the use of immunochemical faecal occult blood test]. Launoy G. Pathol Biol (Paris); 2009 Sep 20; 57(6):488-92. PubMed ID: 18834677 [Abstract] [Full Text] [Related]
7. Cost-effectiveness of mass screening for colorectal cancer: choice of fecal occult blood test and screening strategy. Sobhani I, Alzahouri K, Ghout I, Charles DJ, Durand-Zaleski I. Dis Colon Rectum; 2011 Jul 20; 54(7):876-86. PubMed ID: 21654256 [Abstract] [Full Text] [Related]
9. Immunoassay-based screening for colorectal cancer. More colonoscopies performed and more cancers detected than with Haemoccult. Prescrire Int; 2012 Dec 20; 21(133):299-302. PubMed ID: 23373100 [Abstract] [Full Text] [Related]
10. Comparative evaluation of a new bedside faecal occult blood test in a prospective multicentre study. Hoepffner N, Shastri YM, Hanisch E, Rösch W, Mössner J, Caspary WF, Stein J. Aliment Pharmacol Ther; 2006 Jan 01; 23(1):145-54. PubMed ID: 16393292 [Abstract] [Full Text] [Related]
11. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. Allison JE, Sakoda LC, Levin TR, Tucker JP, Tekawa IS, Cuff T, Pauly MP, Shlager L, Palitz AM, Zhao WK, Schwartz JS, Ransohoff DF, Selby JV. J Natl Cancer Inst; 2007 Oct 03; 99(19):1462-70. PubMed ID: 17895475 [Abstract] [Full Text] [Related]
16. Choice of fecal occult blood tests for colorectal cancer screening: recommendations based on performance characteristics in population studies: a WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy) report. Young GP, St John DJ, Winawer SJ, Rozen P, WHO (World Health Organization) and OMED (World Organization for Digestive Endoscopy). Am J Gastroenterol; 2002 Oct 03; 97(10):2499-507. PubMed ID: 12385430 [Abstract] [Full Text] [Related]
17. A population-based comparison of immunochemical fecal occult blood tests for colorectal cancer screening. Raginel T, Puvinel J, Ferrand O, Bouvier V, Levillain R, Ruiz A, Lantieri O, Launoy G, Guittet L. Gastroenterology; 2013 May 03; 144(5):918-25. PubMed ID: 23376426 [Abstract] [Full Text] [Related]
18. Screening for colorectal cancer with immunochemical faecal occult blood tests. Faivre J, Dancourt V, Lejeune C. Dig Liver Dis; 2012 Dec 03; 44(12):967-73. PubMed ID: 22898146 [Abstract] [Full Text] [Related]